Innovative Licensing and Access Pathway
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Read the updated guidance from Medicines and Healthcare products Regulatory Agency published on 5 April 2024.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (21 mai 2024). Innovative Licensing and Access Pathway. ELSIBI. Consulté le 16 mars 2026 à l’adresse https://doi.org/10.58079/11p16





